Mikhail Blagoslonny is a professor at the Roswell Park Cancer Institute. Here he carries out extensive research on cancer and aging which are critical areas of study in the modern world. The scientist, who resides in New York is also oncology professor at the same institution. Blagosklonny is a talented scientist who has a rich educational background.
He studied internal medicine and enrolled for a doctorate because of his desire to excel in the field of research. He studied cardiology and medicine, fields which are essential for its area of interest.
After doing a doctorate, he got an appointment at the New York Medical College where he started serving as an associate professor in the field of medicine. He served the college until in 2002 when he went to Ordway, which is a research institute. Here, he held a position of senior scientist and continued to gain experience which led him to get a position as an oncology professor at Roswell Park Cancer Institute. The institution is well-known for working with scientists to discover ways of helping cancer patients. Through their extensive research, they have found some ways of helping cancer patients. Visit ResearchGate to keep up to date with Mikhail’s latest work.
The institution has every belief that Mikhail Blagosklonny has all it takes to help it in teaching students who are passionate about oncology. Through this position, Mikhail Blogosklonny has worked with other researchers and students. Mikhail is always ready to work with others and help students understand the field so as to become future scientists. At the institution, Mikhail has played a significant role in making a breakthrough on cancer and aging. His primary focus is cancer therapies and protection of healthy cells. He is also focused on the mechanism that underly aging.
Mikhail is also known for the formulation of the hypothesis on TOR as a signal for aging. The theory claims that TOR signaling is a key factor in cancer and aging. If the theory is correct, then drug such as rapamycin could be helpful in the treatment of cancer and extension of life. The scientist also carries out other endeavors such as editing. He works with Aging, Cell Cycle nd Oncotarget journals where he has significant contributions. Follow Mikhail on Google Scholar